Krishna Priya's current project is utilizing next-generation sequencing to better characterize CRISPR gene editing outcomes in R34G mutation-specific NRF2 targeting. She had previously worked on significant association of single nucleotide polymorphism in XRCC1, one of >20 genes that participate in base excision repair pathway and support the hypothesis that XRCC1 Arg399Gln amino acid change may alter the phenotype of XRRCC1 protein, resulting in deficient DNA repair.
Before joining Gene Editing Institute, she worked with Next Generation DNA Sequencing data on the Illumina MiniSeq, to detect genetic variants related to cardiomyopathy, neurodegenerative disorders, cancer, diabetes and pulmonary diseases.
